Cancer Research UK feature examines why only a minority of H. pylori carriers develop stomach cancer
A Cancer Research UK analysis explores the host genetic, microbial, and environmental factors that determine why gastric adenocarcinoma develops in roughly 1% of people infected with H. pylori.
A feature article from Cancer Research UK's news team examines the longstanding question of why Helicobacter pylori infection — present in a large proportion of the world population — leads to gastric adenocarcinoma in only approximately 1% of infected individuals.
The piece synthesises published research on the interplay between bacterial virulence factors (including the cagA pathogenicity island and vacA toxin), host genetic variation in immune response genes, and environmental co-factors such as diet and smoking. Variation in immune-related genes, including those governing interleukin signalling and toll-like receptor responses, has been associated in published literature with differential susceptibility to H. pylori-associated gastric pathology.
The article is presented as an accessible research explainer aimed at those following cancer biology rather than as a primary research publication. It draws on existing peer-reviewed literature to contextualise a complex gene-environment interaction that has implications for understanding hereditary and population-level cancer risk. No new primary data are presented.
For researchers and oncologists, the piece serves as a useful synthesis of current understanding of gastric carcinogenesis pathways. Educators and students may find it a clear entry point into the topic of gene-environment interaction in cancer susceptibility.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source Cancer Research UK · 2026-05-18The gatekeeper and the invader – H.pylori and the development of stomach cancer